Business

Data for the NIH Mix and Match Covid Vaccine Booster Trial will be ready soon

Dr. Anthony Fauci, director of the National Institute of Infectious Diseases, makes an opening statement at a hearing of the Senate Health, Education and Labor Pensions Committee to discuss the federal government’s ongoing response to COVID-19 at the U.S. Capitol. .. Washington DC, May 11, 2021.

Greg Nash | Pool | Reuters

Dr. Anthony Fauci, Chief Medical Advisor to the White House, said on Tuesday that safety and efficacy data on the pairing of one manufacturer’s Covid vaccine primary regimen with another manufacturer’s booster will be available within the next two weeks. Said there is a possibility.

Centers for Disease Control and Prevention Certified Pfizer Booster For seniors and medically vulnerable Fridays Pfizer The first two doses are subject to the third shot. However, the National Institutes of Health is on the verge of completing a mixed trial of boosters and initial doses from Pfizer. Modana When Johnson & JohnsonFauci said at the White House’s Covid Briefing.

“Like everything we do, they must be submitted to the FDA for regulatory approval,” Fauci said of the so-called mix-and-match exam. “So you don’t want to stay ahead of the FDA, but at least that’s where the data is now.”

Data on the Johnson & Johnson mix-and-match study may be ready within a week, and Pfizer’s trials may be completed by mid-October. Moderna’s mix-and-match research data is already available, Fauci added.

Pfizer and Modana vaccines mRNA technology To fight Covid, J & J Adenovirus Strengthens the body’s immune response. Vaccines and boosters can be combined in combination, giving vaccine recipients greater flexibility in choosing a third shot to enhance the weakened immunity of the first dose. ..

Fauci’s comments came a few days after NIH director Dr. Francis Collins. The agency said We were still looking at the results of combining initial doses from different vaccine manufacturers with booster immunization. Collins added that Moderna and J & J are evaluating boosters a few weeks away from the CDC and FDA.

NIH announces the start of mixed and match vaccine trials June 1This included approximately 150 adults vaccinated with Pfizer, Moderna, or J & J. Participants were boost-immunized with a different third dose approximately 3-4 months after receiving the first vaccine.

Data for the NIH Mix and Match Covid Vaccine Booster Trial will be ready soon

Source link Data for the NIH Mix and Match Covid Vaccine Booster Trial will be ready soon

Back to top button